Evidence map›Paper›PMID 22727807›Full record

ArticleJournal of pharmaceutical and biomedical analysis2012

A novel ultrasensitive LC-MS/MS assay for quantification of intracellular raltegravir in human cell extracts.

Brian L Robbins, Sarah R Nelson, Courtney V Fletcher

Open access · greenAbstract readComparative StudyValidation Study
In one paragraph

Article in Journal of pharmaceutical and biomedical analysis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Quantification of nine antiretroviral drugs in cerebrospinal fluid: An approach to overcome sample collection tube adsorption.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Brian L RobbinsAntiviral Pharmacology Laboratory, University of Nebraska Medical Center, Omaha, NE 68198-6045, USA. blrobbins@unmc.edu
Sarah R Nelson
Courtney V Fletcher
University of Nebraska Medical Center · US

Funding

Virological Measurements of Cryptic ReplicationP01AI074340 · NIAID · UNIVERSITY OF MINNESOTA · PI SCHACKER, TIMOTHY W · 2008 to 2012
$12.1M
Antifibrotic Therapy to Improve Immune reconstitution in HIVR01AI093319 · NIAID · UNIVERSITY OF MINNESOTA · PI SCHACKER, TIMOTHY W · 2011 to 2014
$2.8M
NIAID NIH HHS P01 AI074340NIAID NIH HHS R01 AI093319NIAID NIH HHS R01AI093319
6 · The paper itself

Abstract

An assay using ultrahigh pressure liquid chromatography and mass spectrometry detection was developed and validated for measurement of the HIV integrase inhibitor raltegravir (MK-0518) in human cell extracts. The assay is designed to utilize 200 μl of 70% MeOH cell extract derived from human peripheral blood mononuclear cells or human tissue samples. The assay is linear over a range from 0.0023 to 9.2 ng ml(-1). The average %CV (SD/Mean)*100 and %deviation ((observed-target)/target)*100 were less than 20% at the lower limit of quantification and less than 15% over the range of the curve. This assay is an accurate and highly sensitive method for determining raltegravir concentrations in cellular extracts with a lower limit 40 to over 100-fold lower than other methods in the literature. We also present a new processing method where a rapid spin through oil produced a significant increase in apparent intracellular raltegravir concentration compared with conventional processing.

Indexed as

Chromatography, High Pressure LiquidTandem Mass SpectrometryCalibrationCell ExtractsCentrifugationDrug StabilityHIV Integrase InhibitorsHumansLeukocytes, MononuclearLimit of DetectionLinear ModelsMethanolPyrrolidinonesRaltegravir PotassiumReference StandardsReproducibility of ResultsCell ExtractsHIV Integrase InhibitorsMethanolPyrrolidinonesRaltegravir Potassium

Identifiers

PMID22727807
PMCPMC3443311
OpenAlexW2123530170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.